We also show for the first time the in vivo effect in asthma of the reference MSK1 inhibitor PHA767491, with activity comparable to that of H89 provided previously [14], thus consolidating the implication of the MSK1 kinase in asthma. This evidence concerns the gene RPS6KA5 and asthma.